Runx1 alleviates osteoarthritis progression in aging mice

References

• Rahmati M, Nalesso G, Mobasheri A, et al. Aging and osteoarthritis: central role of the extracellular matrix. Ageing Res Rev. 2017;40:20–30. doi: 10.1016/j.arr.2017.07.004
   PubMed Web of Science ®Google Scholar
• Loeser RF. Aging processes and the development of osteoarthritis. Curr Opin Rheumatol. 2013;25(1):108–113. doi: 10.1097/BOR.0b013e32835a9428
   PubMed Web of Science ®Google Scholar
• Leyland KM, Hart DJ, Javaid MK, et al. The natural history of radiographic knee osteoarthritis: a fourteen-year population-based cohort study. Arthritis Rheum. 2012;64(7):2243–2251.
   PubMedGoogle Scholar
• Loeser RF. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage. 2009;17(8):971–979. doi: 10.1016/j.joca.2009.03.002
   PubMed Web of Science ®Google Scholar
• Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage. 2007;15(9):1061–1069. doi: 10.1016/j.joca.2007.03.006
   PubMed Web of Science ®Google Scholar
• Cicuttini FM, Spector TD. Osteoarthritis in the aged. Epidemiological issues and optimal management. Drugs Aging. 1995;6(5):409–420. doi: 10.2165/00002512-199506050-00007
   PubMed Web of Science ®Google Scholar
• Greene MA, Loeser RF. Aging-related inflammation in osteoarthritis. Osteoarthritis Cartilage. 2015;23(11):1966–1971. doi: 10.1016/j.joca.2015.01.008
   PubMed Web of Science ®Google Scholar
• Xu L, Wu Z, He Y, et al. MFN2 contributes to metabolic disorders and inflammation in the aging of rat chondrocytes and osteoarthritis. Osteoarthritis Cartilage. 2020;28(8):1079–1091.
   PubMed Web of Science ®Google Scholar
• Loeser RF. The role of aging in the development of osteoarthritis. Trans Am Clin Climatol Assoc. 2017;128:44–54.
   PubMedGoogle Scholar
• Loeser RF, Goldring SR, Scanzello CR, et al. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64(6):1697–1707.
   PubMed Web of Science ®Google Scholar
• Hwang HS, Kim HA. Chondrocyte apoptosis in the pathogenesis of osteoarthritis. Int J Mol Sci. 2015;16(11):26035–26054. doi: 10.3390/ijms161125943
   PubMed Web of Science ®Google Scholar
• Hall M, van der Esch M, Hinman RS, et al. How does hip osteoarthritis differ from knee osteoarthritis? Osteoarthritis Cartilage. 2022;30(1):32–41.
   PubMed Web of Science ®Google Scholar
• Xia BJ, Chen D, Zhang JS, et al. Osteoarthritis pathogenesis: a review of molecular mechanisms. Calcif Tissue Int. 2014;95(6):495–505.
   PubMed Web of Science ®Google Scholar
• Vincent TL. Mechanoflammation in osteoarthritis pathogenesis. Semin Arthritis Rheum. 2019;49(3S):S36–S38. doi: 10.1016/j.semarthrit.2019.09.018
   PubMedGoogle Scholar
• Klco JM, Mullighan CG. Advances in germline predisposition to acute leukaemias and myeloid neoplasms. Nat Rev Cancer. 2021;21(2):122–137. doi: 10.1038/s41568-020-00315-z
   PubMed Web of Science ®Google Scholar
• McCarroll CS, He WH, Foote K, et al. Runx1 deficiency protects against adverse cardiac remodeling after myocardial infarction. Circulation. 2018;137(1):57–70.
   PubMed Web of Science ®Google Scholar
• Kimura A, Inose H, Yano F, et al. Runx1 and Runx2 cooperate during sternal morphogenesis. Development. 2010;137(7):1159–1167.
   PubMed Web of Science ®Google Scholar
• Yokomizo-Nakano T, Sashida G. Two faces of RUNX3 in myeloid transformation. Exp Hematol. 2021;97:14–20. doi: 10.1016/j.exphem.2021.02.005
   PubMed Web of Science ®Google Scholar
• Tang J, Xie J, Chen W, et al. Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation. J Biol Chem. 2020;295(33):11669–11681.
   PubMed Web of Science ®Google Scholar
• Tang CY, Chen W, Luo Y, et al. Runx1 up-regulates chondrocyte to osteoblast lineage commitment and promotes bone formation by enhancing both chondrogenesis and osteogenesis. Biochem J. 2020;477(13):2421–2438.
   PubMed Web of Science ®Google Scholar
• Luo Y, Zhang YM, Miao GJ, et al. Runx1 regulates osteogenic differentiation of BMSCs by inhibiting adipogenesis through Wnt/β-catenin pathway. Arch Oral Biol. 2019;97:176–184. doi: 10.1016/j.archoralbio.2018.10.028
   PubMed Web of Science ®Google Scholar
• Yuan S, Zhang L, Ji LR, et al. FoxO3a cooperates with RUNX1 to promote chondrogenesis and terminal hypertrophic of the chondrogenic progenitor cells. Biochem Biophys Res Commun. 2022;589:41–47. doi: 10.1016/j.bbrc.2021.12.008
   PubMed Web of Science ®Google Scholar
• Zhou CC, Cui YJ, Yang YY, et al. Runx1 protects against the pathological progression of osteoarthritis. Bone Res. 2021;9(1):50.
   PubMed Web of Science ®Google Scholar
• Yano F, Ohba S, Murahashi Y, et al. Runx1 contributes to articular cartilage maintenance by enhancement of cartilage matrix production and suppression of hypertrophic differentiation. Sci Rep. 2019;9(1):7666.
   PubMedGoogle Scholar
• Xie J, Zhang DM, Lin YF, et al. Anterior cruciate ligament transection-induced cellular and extracellular events in menisci: implications for osteoarthritis. Am J Sports Med. 2018;46(5):1185–1198.
   PubMed Web of Science ®Google Scholar
• Zhou CC, Yang YY, Duan MM, et al. Biomimetic fibers based on equidistant micropillar arrays determines chondrocyte fate via mechanoadaptability. Adv Healthcare Mater. 2023;e2301685. doi: 10.1002/adhm.202301685
   Google Scholar
• Loeser RF, Collins JA, Diekman BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(7):412–420. doi: 10.1038/nrrheum.2016.65
   PubMed Web of Science ®Google Scholar
• Pezzotti G, Zhu WL, Terai Y, et al. Raman spectroscopic insight into osteoarthritic cartilage regeneration by mRNA therapeutics encoding cartilage-anabolic transcription factor Runx1. Mater Today Bio. 2022;13:100210. doi: 10.1016/j.mtbio.2022.100210
   PubMedGoogle Scholar
• Varela-Eirin M, Loureiro J, Fonseca E, et al. Cartilage regeneration and ageing: targeting cellular plasticity in osteoarthritis. Ageing Res Rev. 2018;42:56–71. doi: 10.1016/j.arr.2017.12.006
   PubMed Web of Science ®Google Scholar
• Collins JA, Diekman BO, Loeser RF. Targeting aging for disease modification in osteoarthritis. Curr Opin Rheumatol. 2018;30(1):101–107. doi: 10.1097/BOR.0000000000000456
   PubMed Web of Science ®Google Scholar
• Barnett R. Osteoarthritis. Lancet. 2018;391(10134):1985. doi: 10.1016/S0140-6736(18)31064-X
   PubMed Web of Science ®Google Scholar
• Sacitharan PK. Ageing and osteoarthritis. Subcell Biochem. 2019;91:123–159.
   PubMedGoogle Scholar
• Chen HR, Cui YJ, Zhang DM, et al. The role of fibroblast growth factor 8 in cartilage development and disease. J Cell Mol Med. 2022;26(4):990–999.
   PubMed Web of Science ®Google Scholar
• Yano F, Hojo H, Ohba S, et al. A novel disease-modifying osteoarthritis drug candidate targeting Runx1. Ann Rheum Dis. 2013;72(5):748–753.
   PubMed Web of Science ®Google Scholar
• Bi W, Deng JM, Zhang Z, et al. Sox9 is required for cartilage formation. Nat Genet. 1999;22(1):85–89.
   PubMed Web of Science ®Google Scholar
• Zhao XY, Meng FG, Hu S, et al. The synovium attenuates cartilage degeneration in KOA through activation of the Smad2/3-Runx1 cascade and chondrogenesis-related miRnas. Mol Ther Nucleic Acids. 2020;22:832–845. doi: 10.1016/j.omtn.2020.10.004
   PubMedGoogle Scholar